비교리스트

 카트 문의
시장보고서
상품코드
1335289

암 면역치료 시장 : 기술 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Cancer Immunotherapy Market with COVID-19 Impact Analysis, By Technology Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 321 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 주요 내용

암 면역치료 시장 규모는 2022년 879억 860만 달러로 평가되며 2023년부터 2030년까지 13.8%의 CAGR로 확대

암 면역치료 시장 - 시장 역학:

  • 암 발병률의 증가와 암 치료 요법의 기술 발전이 급증하면서 세계 암 면역치료 시장의 성장을 촉진할 것으로 예상됩니다.
  • 암 발병률이 증가함에 따라 보다 효과적이고 개별화된 치료법에 대한 수요가 증가하고 있습니다. 암 면역치료는 여러 종류의 암 치료에서 유망한 결과를 보였으며 점차 현대 암 치료 기술의 중요한 요소로 간주되고 있습니다. 미국 질병통제예방센터에 따르면 2020년 미국에서는 160만 3,844명의 신규 암 환자가 보고되었고, 60만 2,347명이 암으로 사망했습니다. 인구 10만 명당 403명의 신규 암 환자가 보고되고 144명이 암으로 사망했으며, 2020년은 이환율 데이터를 사용할 수 있는 가장 최근의 해입니다. 암 연구의 급속한 기술 발전은 새로운 치료제와 맞춤형 치료제를 만들어내고 있습니다. 특히 면역치료는 면역관문억제제, CAR-T 세포치료제, 암 백신, 종양 용해성 바이러스 및 기타 혁신적 기술의 출현으로 상당한 진전을 이루었습니다. 신흥국의 의료 인프라가 가속화될수록 암 면역치료가 채택될 수 있는 기회도 늘어날 것으로 보입니다. 그러나 특히 부유하지 않은 국가와 지역에서는 높은 비용으로 인해 많은 환자들이 암 면역치료을 받지 못할 수도 있습니다.

암 면역치료 시장 - 세분화 분석:

  • 암 면역치료 세계 시장은 제품 유형, 용도, 최종사용자 및 지역별로 분류됩니다.
  • 시장은 제품 유형에 따라 세 가지 카테고리, 즉 단일 클론 항체, 사이토카인/면역 조절제, 기타로 나뉩니다. 단클론 항체가 시장을 독점하고 있습니다. 단일클론항체(mAbs)는 암 면역치료의 일종으로 다양한 암 치료에 필수적인 요소입니다. 이들은 암세포와 같은 위험한 감염과 싸우는 면역체계의 능력을 모방할 수 있는 실험실에서 만들어진 화합물입니다.
  • 시장은 용도에 따라 폐암, 유방암, 대장암, 흑색종, 전립선암, 두경부암, 기타 등 6개 카테고리로 나뉩니다. 폐암은 시장을 독점하고 있으며, 예측 기간 동안에도 그 우위를 유지할 것으로 보입니다. 면역 요법은 폐암 치료 옵션을 보완하는 중요한 대안으로 부상하고 있습니다. 화학요법과 방사선 요법은 수년 동안 폐암의 주요 치료 옵션이었습니다.
  • 시장은 최종사용자에 따라 병원, 암 연구 센터, 클리닉의 세 가지로 분류됩니다. 시장 성장을 주도하는 것은 병원 부문입니다. 암 면역치료는 소규모 병원부터 대규모 대학 의료기관에 이르기까지 전 세계 병원과 클리닉에서 널리 채택되고 있습니다.

암 면역치료 시장 - 지리적 인사이트:

지리적으로는 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 아프리카 등 다양한 지역에 분포되어 있습니다. 이 지역들은 사업 진출 국가에 따라 더 세분화되어 있습니다. 북미는 의료비 지출 증가, 암 발병률 증가, 의료 보험에 대한 접근성 증가로 인해 시장 성장을 주도할 것으로 예상됩니다. 북미, 특히 미국은 전 세계 어느 나라보다 1인당 의료비 지출이 높은 지역입니다. 이러한 높은 수준의 지출 덕분에 공공 부문과 민간 부문 모두 면역 요법과 같은 새롭고 비용이 많이 드는 암 치료에 투자할 수 있습니다. 미국 의사협회에 따르면 미국의 의료비는 2021년 2.7% 증가한 4조 3,000억 달러, 국민 1인당 12,914달러에 달할 것으로 예상했습니다. 건강 보험의 유무는 환자가 적시에 양질의 치료를 받을 수 있는지 여부에 큰 영향을 미칩니다. 유럽은 인프라 시장 개척과 암 발병률 증가로 인해 시장 성장에서 두 번째로 큰 지역으로 부상했습니다.

암 면역치료 시장 - 경쟁 상황:

전 세계 암 발병률의 증가와 특정 암에 대한 면역 요법의 효능이 입증됨에 따라 암 면역치료에 대한 수요가 증가하고 있습니다. 이 산업의 기업 개요은 특정 치료제의 효능과 안전성, 치료 가능한 악성 종양의 범위, 가격 책정, 소비자에게 치료제의 가치를 보여줄 수 있는 능력과 같은 요소로 인해 자주 경쟁합니다. 신약과 적응증은 경쟁 우위를 가져올 수 있기 때문에 R&D 파이프라인 측면에서도 경쟁합니다. 이 분야는 최근 몇 년 동안 큰 기술 혁신이 일어나고 있으며, 새로운 치료법과 기술 개발이 진행되고 있습니다. 예를 들어, 화이자는 지난 11월 2022년 11월 자사의 암 면역치료제 엘라나타맙이 미국 식품의약국(FDA)으로부터 재발성 또는 난치성 다발성 골수종(RRMM) 치료제로 획기적인 치료제 지정을 받았다고 발표했습니다.

목차

제1장 암 면역치료 시장 개요

  • 조사 범위
  • 시장 추정 연수

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 암 면역치료 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 시장 동향

제4장 암 면역치료 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 체계 분석

제5장 암 면역치료 시장 : COVID-19의 영향 분석

  • 신종 코로나바이러스 감염증 이전의 영향 분석
  • 신종 코로나바이러스 감염증 후의 영향 분석

제6장 암 면역치료 시장 상황

  • 암 면역치료 시장 점유율 분석, 2022년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 암 면역치료 시장 - 기술 유형별

  • 개요
    • 테크놀러지 유형별 부문 점유율 분석
    • 단클론항체
    • 사이토카인과 면역조절 물질
    • 기타

제8장 암 면역치료 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 폐암
    • 유방암
    • 대장암
    • 흑색종
    • 전립선암
    • 두경부암
    • 기타

제9장 암 면역치료 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원
    • 암 연구 센터
    • 클리닉

제10장 암 면역치료 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 암 면역치료 산업

  • 경쟁 대시보드
  • 기업 개요
    • Pfizer Inc.
    • AstraZeneca
    • Merck &Co., Inc
    • F. Hoffmann-La Roche Ltd
    • Bristol-Myers Squibb Company
    • Novartis AG
    • Lilly
    • Johnson &Johnson Services, Inc
    • Immunocore, Ltd

제12장 애널리스트의 전방위 전망

ksm 23.10.24

REPORT HIGHLIGHT

The Cancer Immunotherapy Market size was valued at USD 87,908.6 Million in 2022, expanding at a CAGR of 13.8% from 2023 to 2030.

Cancer immunotherapy is a sort of cancer treatment that uses the body's own immune system to combat cancer. It works by assisting the immune system in recognizing and attacking cancer cells. Immunotherapy can be used alone or in conjunction with other cancer treatments. Cancer frequently overcomes many of the immune system's natural defenses, allowing cancer cells to proliferate. Different types of immunotherapy work in different ways. Some immunotherapy treatments assist the immune system block or limiting the growth of cancer cells. Others aid the immune system in destroying cancer cells or preventing cancer from spreading to other parts of the body. Immunotherapy has shown promise in treating a variety of cancers and has become a major focus of cancer research.

Cancer Immunotherapy Market- Market Dynamics:

  • The growing incidence of cancer and the surge in technological advancements in cancer treatment therapies are expected to propel the growth of the global cancer immunotherapy market.
  • The expanding cancer burden has produced a critical demand for more effective and tailored treatment alternatives. Cancer immunotherapy has demonstrated encouraging outcomes in treating several types of cancer and is gradually being regarded as an important component of modern cancer treatment techniques. According to the Centers for disease control and Prevention, In the United States in 2020, 1,603,844 new cancer cases were reported and 602,347 people died of cancer. For every 100,000 people, 403 new cancer cases were reported and 144 people died of cancer. 2020 is the latest year for which incidence data are available. Rapid technological advances in cancer research have resulted in the creation of novel and tailored medicines. Immunotherapy, in particular, has made considerable advances in recognition of the advent of immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, oncolytic viruses, and other innovative techniques. As healthcare infrastructure in emerging nations accelerates, there will be greater opportunities for cancer immunotherapies to be adopted. However, High expenses can prevent many patients from gaining Cancer Immunotherapy, particularly in less rich nations or regions.

Cancer Immunotherapy Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Cancer Immunotherapy market is estimated to grow annually at a CAGR of around 13.8% over the forecast period (2023-2030)
  • The Cancer Immunotherapy industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Lung Cancer was the leading type in 2022
  • Based on End-User segmentation, Hospitals was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Cancer Immunotherapy Market- Segmentation Analysis:

  • The Global Cancer Immunotherapy Market is segmented on the basis of Product Type, Application, End-User, and Region.
  • The market is divided into three categories based on product type: Monoclonal Antibodies, Cytokines & Immunomodulators, and Others. Monoclonal Antibodies dominate the market. Monoclonal antibodies (mAbs) are a type of cancer immunotherapy that has become an essential component in the treatment of various cancers. These are lab-created compounds that can imitate the immune system's ability to combat dangerous infections such as cancer cells.
  • The market is divided into six categories based on application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others. Lung Cancer dominates the market and is likely to maintain its dominance during the forecast period. Immunotherapy has emerged as an important complement to lung cancer treatment options. Chemotherapy and radiation were the principal treatment choices for lung cancer for many years.
  • The market is divided into three categories based on End-User: Hospitals, Cancer Research Centers, and Clinics. The hospital segment dominates the market growth. Cancer immunotherapy is widely employed in hospitals and clinics all over the world, from small hospitals to large university medical institutes.

Cancer Immunotherapy Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, owing to an increase in healthcare expenditure, a rise in the incidence of cancer, and a surge in access to medical insurance. North America, especially the United States, spends more per capita on healthcare than any other country in the world. Because of this high level of spending, both the public and commercial sectors can invest in novel and frequently expensive cancer treatments, such as immunotherapies. According to American Medical Association, Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD12,914 per capita. The availability of health insurance can have a substantial impact on a patient's capacity to receive timely and high-quality care. Europe is the second largest region for the growth of the market, owing to the development in the infrastructure in the region and rising incidences of cancer.

Cancer Immunotherapy Market- Competitive Landscape:

The expanding worldwide burden of cancer and the established efficacy of immunotherapies in treating specific forms of cancer have increased the demand for cancer immunotherapy. Companies in this industry frequently compete on factors such as particular treatments' efficacy and safety profile, the spectrum of malignancies their medications can treat, pricing, and their ability to demonstrate the value of their therapies to consumers. They compete in terms of their R&D pipelines as well, as novel medicines and indications can provide a competitive advantage. This field has seen major innovation in recent years, leading to the development of new therapies and techniques. For example, on November 2022, Pfizer Inc. nowadays announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the treatment of people with relapsed or refractory multiple myeloma (RRMM).

Recent Developments:

On June 2023, Merck, known as MSD outside of the United States and Canada, nowadays announced the U.S. Food and Drug Administration (FDA) has accepted for review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA, Merck's anti-PD-1 therapy, in combination with standard of care chemotherapy for the treatment of patients with locally advanced unrespectable or metastatic biliary tract cancer (BTC).

Key features of the study:

  • This proposed research study on Cancer Immunotherapy market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Cancer Immunotherapy market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer Immunotherapy market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer Immunotherapy market
  • Impact of COVID-19 on Cancer Immunotherapy market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer Immunotherapy market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Cancer Immunotherapy market, we have also included competitive landscape and key innovator analysis for the Cancer Immunotherapy market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Cancer Immunotherapy market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Cancer Immunotherapy market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER IMMUNOTHERAPY MARKET KEY PLAYERS

  • Pfizer Inc.
  • AstraZeneca
  • Merck & Co., Inc
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Lilly
  • Johnson & Johnson Services, Inc
  • Immunocore, Ltd

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY TECHNOLOGY TYPE

  • Monoclonal Antibodies
  • Cytokines & Immunomodulators
  • Others

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY APPLICATION

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head & Neck Cancer
  • Others

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY END-USER

  • Hospitals
  • Cancer Research Centers
  • Clinics

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Immunotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Immunotherapy Market Snippet by Technology Type
    • 2.1.2. Cancer Immunotherapy Market Snippet by Application
    • 2.1.3. Cancer Immunotherapy Market Snippet by End-User
    • 2.1.4. Cancer Immunotherapy Market Snippet by Country
    • 2.1.5. Cancer Immunotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Immunotherapy Key Market Trends

  • 3.1. Cancer Immunotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Immunotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Immunotherapy Market Opportunities
  • 3.4. Cancer Immunotherapy Market Future Trends

4. Cancer Immunotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Immunotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Immunotherapy Market Landscape

  • 6.1. Cancer Immunotherapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Immunotherapy Market - By Technology Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology Type, 2022 & 2030 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Cytokines & Immunomodulators
    • 7.1.4. Others

8. Cancer Immunotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Lung Cancer
    • 8.1.3. Breast Cancer
    • 8.1.4. Colorectal Cancer
    • 8.1.5. Melanoma
    • 8.1.6. Prostate Cancer
    • 8.1.7. Head & Neck Cancer
    • 8.1.8. Others

9. Cancer Immunotherapy Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Cancer Research Centers
    • 9.1.4. Clinics

10. Cancer Immunotherapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Immunotherapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Immunotherapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Immunotherapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cancer Immunotherapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cancer Immunotherapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Cancer Immunotherapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. AstraZeneca
    • 11.2.3. Merck & Co., Inc
    • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.5. Bristol-Myers Squibb Company
    • 11.2.6. Novartis AG
    • 11.2.7. Lilly
    • 11.2.8. Johnson & Johnson Services, Inc
    • 11.2.9. Immunocore, Ltd

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제